Table of Contents
Rencarex (Renal Cell Carcinoma)- Analysis and Forecasts to 2022 Summary GlobalData’s pharmaceuticals report, “Rencarex (Renal Cell Carcinoma)- Analysis and Forecasts to 2022” provides Torisel sales forecasts for US and EU5. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (20...More »
The Largest Collection of Market Research Reports
From +200,000 authoritative sources
Talk to Robyn
(866) 682 9815
"Analytical Tool - Hematological Cancers" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in R&D and business development in hematological cancers. It is ...
Actonel (Osteoporosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Actonel (Osteoporosis) - Forecast and Market Analysis to 2022?. ...
REPORT SCOPE INTRODUCTION REASONS FOR DOING THE STUDY The spread of human immunodeficiency virus (HIV), hepatitis B and C, evolving influenza strains and antibiotic-resistant organisms have put healthcare ...
... Guidelines say People with diabetes and hypertension should be treated to a systolic blood pressure goal of 140 mmhg. Lower systolic targets (such as ...
... To target chronic pain market with a novel opioid: Slow rate of entry into cns designed to: Reduce abuse liability Reduce drowsiness Reduce respiratory depression Long-acting profile Properties ...
Reportlinker.com © Copyright 2013. All rights reserved.